Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Bal Pharma Ltd.
Swot
Bal Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Bal Pharma Ltd. has 13 Strengths, 8 Weaknesses, 2 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(13)
Weakness
(8)
Opportunity
(2)
Threats
(0)
Others
(2)
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Strong Performer, Under Radar Stocks (DVM)
Undervalued Growth Stocks
Value Stocks, Under Radar (DVM)
Rising Net Cash Flow and Cash from Operating activity
Strong Annual EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Affordable Stocks - Stocks with Good Trendlyne Valuation Score
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Book Value per share Improving for last 2 years
Company with Zero Promoter Pledge
Companies with growing costs YoY for long term projects
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Declining Revenue every quarter for the past 3 quarters
Fall in Quarterly Revenue and Net Profit (YoY)
Companies Increasing Debt as per Annual Report
Increasing Trend in Non-Core Income
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
FII / FPI or Institutions increasing their shareholding
Companies with improving valuation scores after share price falls
Rising Delivery Percentage Compared to Prev Day
Decline in Net Profit with falling Profit Margin (QoQ)
